Charles & Colvard (CTHR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Riverstyx Capital Management and affiliates, holding approximately 17% of shares pre-dilution, are soliciting proxies to elect four nominees to the board at the October 13, 2025 annual meeting, aiming to replace four incumbent directors and effect a change in board control.
The solicitation is in response to concerns over financial discipline, dilutive financings, and strategic missteps, including a recent large stock issuance and failure to adapt to market trends in lab-grown diamonds.
Riverstyx's plan includes restoring the balance sheet, improving governance, simplifying the product mix, and focusing on certified lab-grown gemstones to rebuild customer trust and drive long-term value.
Voting matters and shareholder proposals
The primary proposal is the election of four Riverstyx nominees (Benjamin O. Franklin IV, Michael R. Levin, Duc Pham, Lloyd M. Sems) to the board for a one-year term expiring at the 2026 annual meeting.
Shareholders are urged to vote “FOR ALL” Riverstyx nominees and “AGAINST ALL” company nominees using the BLUE universal proxy card.
Directors are elected by plurality; shareholders may vote for up to five nominees, and only the latest valid proxy counts.
Riverstyx intends to solicit proxies from at least 67% of voting shares required to elect their nominees.
Board of directors and corporate governance
The board currently consists of five directors, all up for annual election; Riverstyx seeks to install four new directors, which would constitute a majority if three or more are elected.
Nominees bring expertise in finance, investment, audit, marketing, and jewelry industry operations; none are current or former company employees or affiliates.
Nominees have entered into a group agreement for indemnification related to their candidacy and proxy solicitation.
If elected, nominees are expected to be independent under SEC rules.
Latest events from Charles & Colvard
- Court-ordered annual meeting set for October 13, 2025, with limited agenda and board elections.CTHR
Proxy Filing1 Dec 2025 - Shareholders face a contested Board election and key governance votes amid ongoing financial challenges.CTHR
Proxy Filing1 Dec 2025 - Director nominations by a shareholder were invalidated; Board to recommend elections at the Annual Meeting.CTHR
Proxy Filing1 Dec 2025 - Shareholders face a contested Board election amid calls for leadership change and strategic overhaul.CTHR
Proxy Filing1 Dec 2025 - Riverstyx seeks board control with three nominees and challenges a dilutive stock issuance.CTHR
Proxy Filing1 Dec 2025 - Board recommends its director slate, annual say-on-pay, and cost-saving measures amid restructuring.CTHR
Proxy Filing1 Dec 2025 - FY2024 saw a 27% sales decline, $14.4M loss, and major liquidity risks for Charles & Colvard.CTHR
Q4 202430 Sep 2025